Form 4 for GILD Gilead Sciences
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-10 · accession 0001127602-25-009295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-10 | GILD | Mercier Johanna | Chief Commercial Off | F - Tax | $117.21 | -3,907 | 124.2K | -3% | -$457.9K |
| D | 2025-03-12 | 2025-03-10 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +8,080 | 128.1K | +7% | — |
| DM | 2025-03-12 | 2025-03-10 | GILD | Mercier Johanna | Chief Commercial Off | A - Grant | $0.00 | +60.1K | 49.0K | New | $0 |
| D | 2025-03-12 | 2025-03-10 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | — | -8,080 | 28.1K | -22% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | F | D | 3,907 | $117.21 | 124,152 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-10 | M | A | 8,080 | — | 128,059 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Restricted Stock Unit | 2025-03-10 | A | A | 11,090 | — | 39,203 | D | — · — to — | 11,090 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 4 | Derivative | Restricted Stock Unit | 2025-03-10 | M | D | 8,080 | — | 28,113 | D | — · — to — | 8,080 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-03-10 | A | A | 49,020 | $0.00 | 49,020 | D | $117.21 · — to 2035-03-10 | 49,020 Common Stock | (F3) The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |